Dilemma of new medical frontier as genetic testing advances

BRISBANE: Advances in the understanding of how our bodies work are coming more rapidly than ever before.

Increasingly, it seems, these discoveries are linked to the genetic information locked inside our DNA molecules and how this code exerts its effect on us.

Genomics is the name given to this area of medicine and it strives to understand how an organism’s DNA (genome) drives the production of proteins, which in turn make up organs or become messenger proteins that can amplify, diminish or even turn off the production of other targeted proteins.

Genetic disease results from having inherited faulty genes. Many of these conditions are autosomal recessive and require two defective genes (one from each parent who typically do not display any of the disease symptoms) for the resultant child to have the genetic disorder.

The most common genetic disease in Australia’s caucasian population is cystic fibrosis. It affects the body’s ability to absorb nutrients and also causes production of thick mucus which can lead to chronic lung disease.

Fragile X syndrome can lead to intellectual disability and behavioural problems and spino-muscular atrophy is a progressive degenerative muscle disease frequently leading to early death.

Ideally, a woman in the first trimester of pregnancy or prior to starting a family should be made aware of available genetic tests to see if she carries these three genetic conditions. If found to be a carrier, further testing can be offered to find out if her baby is affected and in this way, better inform the woman of her choices, including whether she continues with the pregnancy.

While this level of genomic testing is recommended by both government and standards bodies, there is no Medicare funding for these tests and women who choose to have them need to pay for them out of their own pocket.

The technology exists for many more gene tests to be undertaken, with so-called “extended panel” tests examining hundreds of genes commercially available now. This level of genomic testing is welcome and may bring some much- needed answers to couples grappling with inheritable disease and a desire to start a family with children free from what can sometimes be terrible afflictions. If not already available, it won’t be long before parents can also select embryos to be implanted with a chosen hair colour, IQ and even body shape.

Gender selection, although available overseas, is currently illegal in Australia.

The science of genomics will continue to give us increasing amounts of information. The challenge we as a ­society face, is how best to use this ­information and with whom the responsibility lies for its use.

I believe this decision should not be left solely to the medical profession and should involve members of the population at large. Deciding which genes are passed on to the next generation is a complex ethical issue.

While avoiding disease-carrying genes may be less controversial, other uses of the technology are more difficult and require input from the general population, community leaders and politicians.

Science can tell us which genes we can detect and choose to pass on, but society should decide whether we should.

Associate Professor Gino Pecoraro is an obstetrician and gynaecologist